Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.07B |
| 2 |
ExxonMobil
XOM
|
+$648M |
| 3 |
Merck
MRK
|
+$572M |
| 4 |
MetLife
MET
|
+$383M |
| 5 |
Chevron
CVX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$798M |
| 2 |
AbbVie
ABBV
|
+$625M |
| 3 |
TSMC
TSM
|
+$622M |
| 4 |
Cisco
CSCO
|
+$507M |
| 5 |
Goldman Sachs
GS
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.86% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.44% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Ascent Industries
ACNT
$136M
| $147K | ﹤0.01% |
13,192
| – | – |
|
|
GATO
3877
DELISTED
Gatos Silver, Inc.
GATO
| $147K | ﹤0.01% |
10,531
| – | – |
|
|
RAPT
3878
DELISTED
RAPT Therapeutics
RAPT
| $142K | ﹤0.01% |
11,268
-8
| -0.1% | -$102 |
|
3879
VirTra
VTSI
$38.2M
| $142K | ﹤0.01% |
21,094
+3,022
| +17% | +$20.4K |
|
3880
Anixa Biosciences
ANIX
$110M
| $136K | ﹤0.01% |
58,746
+1
| +0% | +$3 |
|
3881
AirSculpt Technologies
AIRS
$244M
| $132K | ﹤0.01% |
25,476
-35,366
| -58% | -$217K |
|
3882
Metagenomi Therapeutics
MGX
$46.5M
| $130K | ﹤0.01% |
+36,091
| New | +$87.1K |
|
3883
Skye Bioscience
SKYE
$19.3M
| $127K | ﹤0.01% |
44,908
+1
| +0% | +$4 |
|
3884
PepGen
PEPG
$207M
| $127K | ﹤0.01% |
33,487
| – | – |
|
3885
Greenwich LifeSciences
GLSI
$241M
| $126K | ﹤0.01% |
11,203
| – | – |
|
|
NGD
3886
DELISTED
New Gold Inc
NGD
| $125K | ﹤0.01% |
50,292
+5,331
| +12% | +$14.7K |
|
|
NOTE
3887
DELISTED
FiscalNote
NOTE
| $121K | ﹤0.01% |
9,399
| – | – |
|
3888
The ONE Group
STKS
$56.5M
| $119K | ﹤0.01% |
41,053
-24,158
| -37% | -$80.3K |
|
3889
KLX Energy Services
KLXE
$35.7M
| $118K | ﹤0.01% |
23,650
-28,401
| -55% | -$148K |
|
3890
Key Tronic
KTCC
$42.7M
| $118K | ﹤0.01% |
28,238
+1
| +0% | +$5 |
|
|
CLYM
3891
Climb Bio
CLYM
$840M
| $117K | ﹤0.01% |
64,914
| – | – |
|
|
HIMX
3892
Himax Technologies
HIMX
$2.59B
| $117K | ﹤0.01% |
14,491
-544
| -4% | -$3.43K |
|
|
NINE
3893
DELISTED
Nine Energy Service
NINE
| $116K | ﹤0.01% |
103,594
| – | – |
|
|
AKYA
3894
DELISTED
Akoya BioSciences
AKYA
| $116K | ﹤0.01% |
50,665
-5,717
| -10% | -$15.1K |
|
3895
Emergent Biosolutions
EBS
$234M
| $116K | ﹤0.01% |
12,109
| – | – |
|
3896
Inovio Pharmaceuticals
INO
$93.5M
| $113K | ﹤0.01% |
61,638
+425
| +0.7% | +$1.88K |
|
3897
Karyopharm Therapeutics
KPTI
$45.8M
| $112K | ﹤0.01% |
11,088
| – | – |
|
|
EQC
3898
DELISTED
Equity Commonwealth
EQC
| $110K | ﹤0.01% |
62,231
-537,327
| -90% | -$8.27M |
|
3899
908 Devices
MASS
$417M
| $110K | ﹤0.01% |
49,930
| – | – |
|
3900
Strawberry Fields REIT
STRW
$195M
| $109K | ﹤0.01% |
+10,340
| New | +$120K |
|
Similar funds
Bank of New York Mellon's Q4 2024 Portfolio in Review
As of Q4 2024, Bank of New York Mellon held 4,232 positions worth $541B, up 0.69% from $538B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Bank of New York Mellon's Q4 2024 filing shows 139 new, 1,799 increased, 1,997 reduced and 116 closed positions. Its largest new stake was Fidelity Total Bond ETF: 1,758,308 shares worth $78.9M. The largest sale was Broadcom, an estimated $798M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2024 buy was Fidelity Total Bond ETF: 1,758,308 shares worth $78.9M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $1.07B increase.
- Bank of New York Mellon's biggest Q4 2024 reduction was Broadcom, cutting an estimated $798M.
- Bank of New York Mellon fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $131M.
- Bank of New York Mellon's ten largest holdings make up 26% of its $541B portfolio in Q4 2024.
- Bank of New York Mellon opened 139 new positions and closed 116 in Q4 2024.
- Bank of New York Mellon's portfolio value rose 0.69% quarter-over-quarter to $541B.
Based on Bank of New York Mellon's 13F filing for Q4 2024, filed 4 Feb 2025.